There's very little change overall to the patent framework; there are two. The first is the patent restoration that I was referring to.
To finish the comment I was making on that, Canada does have the wherewithal to speed up the approval of drugs. If that's the case, there is a question about whether there would be any significant extra costs if Canada has a more streamlined system. That's something we can control.